March 29 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* CYNATA EXPANDS MEND CLINICAL TRIAL IN COVID-19 AND RESPIRATORY FAILURE
* CYNATA - EXPANSION TO ENABLE RECRUITMENT OF PATIENTS WITH RESPIRATORY FAILURE ARISING FROM OTHER CAUSES, WITH COVID-19 NO LONGER A REQUIREMENT